Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Research Services
Crohn's Colitis Cure is a Research Services brand in Pyrmont, New South Wales. Ownership is a nonprofit; it publishes at c-c-cure.org. It holds one address on record, all in Australia. The record counts 8 people. Tagged research. One Australian registration (ABN) is a confirmed match. It is listed alongside five similar brands, mostly in Non-profit Organizations.
ABN85154588717
| CROHN'S COLITIS CURE | ABN 85154588717 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Who are we?
Our purpose is to ‘transform patient outcomes’ in Inflammatory Bowel Disease (IBD) and be ‘instrumental in finding a cure’.
A small group of passionate physicians in the field of IBD, from Australia and the UK, began this journey in 2011. Partnering with with a software development company, we developed and run a scalable cloud-based software tool (Crohn’s Colitis Care – CCCare) on Microsoft Azure. This knowledge-based, physical “asset” (CCCare) enables ongoing collection, refresh and use of patient data for research into IBD.
How does it work?
CCCare is an integrated tool which encompasses:
- a patient clinical system, with privacy safeguards, through which individual care is managed and ongoing specific structured patient data is captured;
- a clinical quality registry, where de-identified longitudinal data is captured and can be interrogated to provide specific and targeted insights (and can be married with genetic and bio-markers from stored samples); and
- a research database, where extended data with ethics-approved focus resides
Independent feedback from external organisations in the IBD space have confirmed that our data is deep, focused, and constantly refreshed through the patient/clinician interaction - in a way which many IBD databases cannot.
Partnership opportunities
We have recently developed a new 3-year strategy which transforms our ambition and trajectory — moving from a primary focus on the development of our technology core, to placing the majority of our effort into research.
We are in ongoing conversations to expand our partner base and welcome additional discussions from organisations who share our vision to transform patient outcomes and be instrumental in finding a cure in IBD.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One New South Wales entity on the ABR. CROHN'S COLITIS CURE (ABN 85 154 588 717), high confidence.
The record holds 8 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: 100 Harris St, Level 3, Pyrmont, New South Wales 2009.
None linked to this brand.
Six tags on the brand's own list, among them research.
Five peer profiles on record: Chimera Legacy Foundation and GESA: Gastroenterological Society of Australia.